Sign in
Home
Biotech Insights
Biotech News
CEO Interviews
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Privacy Policy
Password recovery
Recover your password
your email
Search
Sign in / Join
About Us
Privacy Policy
Disclaimer
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Home
Biotech Insights
Biotech News
CEO Interviews
CEO Interviews
BiotechStocktrader Interview with Nader Pourhassan, CEO of Cytodyn, Inc.
CEO Interviews
BiotechStocktrader Interview with Dr. Carl Schwartz, CEO of Precision Therapeutics, (AIPT).
CEO Interviews
BriaCell Therapeutics (BCTXF) Presents Positive Efficacy Data with Lead Cancer Drug Candidate
CEO Interviews
Hemispherx Biopharma (HEB) Showing Strong Progress in Clinical Trials
CEO Interviews
Innovus Pharmaceuticals Continues Strong Revenue Growth & New Product Rollouts
BioTechStockTrader
About Biotech Stocktrader
Alernative Pharma
Biotech Insights
Biotech News
CEO Interviews
COVID-19
Random
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Oncolytics Biotech® Announces Investigator Sponsored Phase 2 Trial Evaluating Pelareorep-anti-PD-1 Combination Treatment in Triple-Negative Breast Cancer
Guided Therapeutics, Inc.
-
June 25, 2020
0
Generex Biotechnology Subsidiary Olaregen Therapeutix Announces Publication on the Use of Excellagen® for Vascular Repair
Guided Therapeutics, Inc.
-
August 13, 2020
0
MillionPatientsCured.com Is the World’s First Human-Centric Technology to Offer Lifesaving COVID-19 Updates to Empower People to Prevent Disease and...
Guided Therapeutics, Inc.
-
July 2, 2020
0
Biotech News
Home
Biotech News
Biotech News
Guided Therapeutics Submits Clinical Study Protocol to U.S. FDA for LuViva®...
Guided Therapeutics, Inc.
-
July 28, 2020
0
Biotech News
Pressure BioSciences Awarded Pivotal U.S. Patent for Novel, High Pressure Enhanced...
Pressure BioSciences, Inc.
-
August 12, 2020
0
Biotech News
Aclaris Therapeutics Supports Investigator-Initiated Clinical Trial of ATI-450 for Cytokine Release...
Aclaris Therapeutics, Inc.
-
June 17, 2020
0
Biotech News
Cardiol Therapeutics Receives FDA Approval For Investigational New Drug (IND) Application...
Paul Archie
-
September 25, 2020
0
1
2
3
...
22
Page 1 of 22
- Advertisement -
APPLE
Sonoma Pharmaceuticals, MicroSafe Announce Successful Aircraft Compatibility Test for Disinfectant and...
Andrew M.
-
August 3, 2020
0
Biotech Insights
Petaluma, California-based Sonoma Pharmaceuticals (NASDAQ:SNOA) shares jumped 50% on July 29th after announcing a positive development related to its Microcyn technology. In conjunction with...
RECENT POSTS
Cardiol Therapeutics Submits Application for Uplisting to the Nasdaq and Raises Proceeds of Over...
Paul Archie
-
March 2, 2021
Big Pharma Dives Into CBD: Who Could Be Next?
Paul Archie
-
February 22, 2021
Clinical Trials Focus on COVID-19 and Acute Myocarditis
Paul Archie
-
January 19, 2021
Cardiol Therapeutics Announces Completion of Phase I Clinical Study of CardiolRx™
Paul Archie
-
December 22, 2020
